Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin on Cognitive Function and Exercise Capacity
NCT01889056Phase 2Unknown
- Sponsor
- University of Zurich
- Start
- Feb 2013
- Primary completion
- Sep 2013
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin beta in cognitive impairment, sponsored by University of Zurich. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT01889056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01889056.